Vascular endothelial growth factor biology: clinical implications for ocular treatments
- PMID: 17114590
- PMCID: PMC1857529
- DOI: 10.1136/bjo.2006.098426
Vascular endothelial growth factor biology: clinical implications for ocular treatments
Abstract
Decades of research on vascular endothelial growth factor (VEGF) have reached fruition with the recent development of intravitreal anti-VEGF treatments for exudative age-related macular degeneration. VEGF is a critical regulator of angiogenesis and vascular permeability with diverse roles, both pathological and physiological, during development and adulthood. The aim of this article is to review aspects of VEGF biology that may be relevant to the clinical use of anti-VEGF agents in ophthalmology: molecular characteristics and isoforms of VEGF; its roles in vasculogenesis, vascular maintenance and angiogenesis; systemic effects of VEGF inhibition; and properties of current anti-VEGF agents.
Conflict of interest statement
Competing interests: None declared.
Similar articles
-
[VEGF, anti-vEGF and diseases].Bull Acad Natl Med. 2008 Feb;192(2):289-300; discussion 300-2. Bull Acad Natl Med. 2008. PMID: 18819684 Review. French.
-
Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.Curr Opin Ophthalmol. 2009 May;20(3):166-74. doi: 10.1097/ICU.0b013e328329d173. Curr Opin Ophthalmol. 2009. PMID: 19381089 Review.
-
Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.Retina. 2008 Oct;28(9):1308-13. doi: 10.1097/IAE.0b013e31818358b2. Retina. 2008. PMID: 18728623
-
VEGF function in vascular pathogenesis.Exp Cell Res. 2006 Mar 10;312(5):527-37. doi: 10.1016/j.yexcr.2005.11.008. Epub 2005 Dec 5. Exp Cell Res. 2006. PMID: 16330026 Review.
-
[VEGF in age-related macular degeneration. Part I. Physiologic and pathologic role of VEGF].Klin Oczna. 2007;109(1-3):94-6. Klin Oczna. 2007. PMID: 17687924 Review. Polish.
Cited by
-
45S5 Bioactive Glass-Ointment Positively Effects on Wound Healing in Rats by Regulating TNFα, Il-10, VEGF, and TGFβ.J Clin Lab Anal. 2024 Sep;38(17-18):e25094. doi: 10.1002/jcla.25094. Epub 2024 Sep 5. J Clin Lab Anal. 2024. PMID: 39235180 Free PMC article.
-
Comparison of subconjunctivally injected bevacizumab, ranibizumab, and pegaptanib for inhibition of corneal neovascularization in a rat model.Int J Ophthalmol. 2013 Apr 18;6(2):136-40. doi: 10.3980/j.issn.2222-3959.2013.02.05. Print 2013. Int J Ophthalmol. 2013. PMID: 23638411 Free PMC article.
-
Oxidative stress, insulin resistance, dyslipidemia and type 2 diabetes mellitus.World J Diabetes. 2015 Apr 15;6(3):456-80. doi: 10.4239/wjd.v6.i3.456. World J Diabetes. 2015. PMID: 25897356 Free PMC article. Review.
-
The Influence of COVID-19 on the Stability of Patients with Neovascular Age-Related Macular Degeneration with Different Treatment Regimens.Adv Ther. 2022 Apr;39(4):1568-1581. doi: 10.1007/s12325-021-01993-3. Epub 2021 Nov 24. Adv Ther. 2022. PMID: 34817809 Free PMC article.
-
Elevated cell proliferation and VEGF production by high-glucose conditions in Müller cells involve XIAP.Eye (Lond). 2013 Nov;27(11):1299-307. doi: 10.1038/eye.2013.158. Epub 2013 Aug 9. Eye (Lond). 2013. PMID: 23928877 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical